Antitumour effects of PLC-γ1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells

British Journal of Cancer

Volumn 90, Issue 1, 2004, Pages 230-235

  Katterle, Y ^a   Brandt, B H ^b   Dowdy, S F ^c   Niggemann, B ^a   Zanker K S ^a   Dittmar, T ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

c erbB 2; EGFR; Migration; PLC 1; TAT

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYBRID PROTEIN; PHOSPHOLIPASE C INHIBITOR; PROTEIN SH2; TYROSINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CALCIUM TRANSPORT; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REDUCTION; SIGNAL TRANSDUCTION;

ADENOMA; BREAST NEOPLASMS; CELL DIVISION; CELL MOVEMENT; GENE PRODUCTS, TAT; GENES, ERBB-1; HUMANS; NEOPLASM METASTASIS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0842308379     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601506     Document Type: Article

References (20)

1. Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL (2001) TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem 276: 30499-30503
2. Alroy I, Yarden Y (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410: 83-86
3. Brandt BH, Roetger A, Dittmar T, Nikolai G, Seeling M, Merschjann A, Nofer J-R, Dehmer-Moeller G, Junker R, Assmann G, Zänker KS (1999) c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB J 13: 1939-1949
4. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J (2002) In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 22: 5423-5431
5. Chen P, Murphy-Ullrich JE, Wells A (1996) A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol 134: 689-698
6. Dittmar T, Husemann A, Schewe Y, Nofer JR, Niggemann B, Zänker KS, Brandt BH (2002) Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J 16: 1823-1825
7. Dittmar T, Schafer F, Brandt BH, Zänker KS (2000) Accelerated assessing of antisense RNA efficacy using a chimeric enhanced green fluorescent protein-antisense RNA-producing vector. Antisense Nucleic Acid Drug Dev 10: 401-408
8. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J (1998) Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J 17: 414-422
9. Graus-Porta D, Beerli RR, Daly JM, Hynes NE (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655
10. Harada H, Hiraoka M, Kizaka-Kondoh S (2002) Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res 62: 2013-2018
11. Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A (1999) A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res 5: 2251-2260
12. Kilic E, Dietz GP, Hermann DM, Bahr M (2002) Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann Neurol 52: 617-622
13. Lang K, Niggemann B, Zänker KS, Entschladen F (2002) Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop. Int J Cancer 99: 673-680
14. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4: 1449-1452
15. Piccolo E, Innominato PF, Mariggio MA, Maffucci T, Iacobelli S, Falasca M (2002) The mechanism involved in the regulation of phospholipase C gamma1 activity in cell migration. Oncogene 21: 6520-6529
16. Rossler P, Kroner C, Freitag J, Noe J, Breer H (1998) Identification of a phospholipase C beta subtype in rat taste cells. Eur J Cell Biol 77: 253-261
17. Schwarze SR, Dowdy SF (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21: 45-48
18. Thor AD, Edgerton SM, Liu S, Moore DH, Kwiatkowski DJ (2001) Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res 7: 2415-2424
19. Turner T, Chen P, Goodly LJ, Wells A (1996) EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metast 14: 409-418
20. Wells A, Ware MF, Allen FD, Lauffenburger DA (1999) Shaping up for shipping out: PLC gamma signaling of morphology changes in EGF-stimulated fibroblast migration. Cell Motil Cytoskeleton 44: 227-233